BioNTech Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . BioNTech SE
BNTX Stock  USD 113.75  3.02  2.59%   
BioNTech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BioNTech's valuation are provided below:
Gross Profit
2.6 B
Profit Margin
(0.18)
Market Capitalization
28.5 B
Enterprise Value Revenue
3.2331
Revenue
3.2 B
We have found one hundred twenty available fundamental signals for BioNTech SE, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of BioNTech SE prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

BioNTech Total Revenue

6 Billion

Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Net Interest Income of 513.2 M, Interest Income of 528.4 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 10.38, Dividend Yield of 0.011 or PTB Ratio of 1.27. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Build AI portfolio with BioNTech Stock
Check out the analysis of BioNTech Correlation against competitors.

BioNTech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets27.2 B25.9 B8.5 B
Slightly volatile
Short and Long Term Debt Total175.4 M292.3 M121.3 M
Slightly volatile
Other Current Liabilities2.1 B2 B647.3 M
Slightly volatile
Total Current Liabilities1.5 B2.9 B990.2 M
Slightly volatile
Property Plant And Equipment Net1.4 B1.4 B435.4 M
Slightly volatile
Current Deferred Revenue192.3 M339.1 M135.6 M
Slightly volatile
Accounts Payable515.2 M490.7 M141.8 M
Slightly volatile
Cash11.8 B11.2 B3.8 B
Slightly volatile
Non Current Assets Total4.5 B4.3 B1.2 B
Slightly volatile
Cash And Short Term Investments20.3 B19.3 B5.5 B
Slightly volatile
Net Receivables2.9 B1.8 B1.7 B
Slightly volatile
Good Will459.6 M437.7 M107.1 M
Slightly volatile
Common Stock Total Equity185.2 M283.3 M136.2 M
Slightly volatile
Short Term Investments8.5 B8.1 B1.7 B
Slightly volatile
Liabilities And Stockholders Equity27.2 B25.9 B8.5 B
Slightly volatile
Non Current Liabilities Total409 M684.7 M367.6 M
Slightly volatile
Inventory204.3 M325.8 M130.7 M
Slightly volatile
Other Current Assets256.8 M244.6 M89.3 M
Slightly volatile
Total Liabilities1.9 B3.6 B1.4 B
Slightly volatile
Property Plant And Equipment Gross1.8 B1.7 B515.9 M
Slightly volatile
Total Current Assets22.7 B21.6 B7.3 B
Slightly volatile
Short Term Debt34.1 M45.4 M22.2 M
Slightly volatile
Intangible Assets954.4 M909 M246.8 M
Slightly volatile
Common Stock224.2 M285.9 M139 M
Slightly volatile
Net Working Capital19.7 B18.7 B6.2 B
Slightly volatile
Capital Stock261.5 M285.9 M221 M
Slightly volatile

BioNTech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income528.4 M503.2 M128.3 M
Slightly volatile
Depreciation And Amortization359.8 M342.7 M91.8 M
Slightly volatile
Interest Expense15.9 M15.1 M4.9 M
Slightly volatile
Selling General Administrative641.3 M610.8 M198.9 M
Slightly volatile
Selling And Marketing Expenses82 M78.1 M27.7 M
Slightly volatile
Total Revenue6 B3.2 B3.1 B
Slightly volatile
Gross Profit5 B2.5 B2.6 B
Slightly volatile
Other Operating Expenses4.9 B4.7 B1.6 B
Slightly volatile
Research Development2.7 B2.6 B796.3 M
Slightly volatile
Cost Of Revenue982.8 M622.5 M518.7 M
Slightly volatile
Total Operating Expenses4.3 B4.1 B1.1 B
Slightly volatile
Reconciled Depreciation359.8 M342.7 M91.8 M
Slightly volatile

BioNTech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation59.2 M116 M38.1 M
Slightly volatile
Begin Period Cash Flow14.1 B13.4 B3.5 B
Slightly volatile
Depreciation359.8 M342.7 M91.8 M
Slightly volatile
Capital Expenditures269.1 M520.1 M185.3 M
Slightly volatile
End Period Cash Flow11.8 B11.2 B3.7 B
Slightly volatile
Change To Netincome1.5 B1.4 B486.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.3810.9231.8603
Slightly volatile
Dividend Yield0.0110.01230.0134
Slightly volatile
Days Sales Outstanding11018292.9869
Slightly volatile
Stock Based Compensation To Revenue0.07720.04220.0796
Slightly volatile
Capex To Depreciation3.191.753.9153
Slightly volatile
EV To Sales6.66.9529.517
Slightly volatile
Inventory Turnover2.092.216.4955
Slightly volatile
Days Of Inventory On Hand18117260.4608
Slightly volatile
Payables Turnover1.081.145.2054
Pretty Stable
Sales General And Administrative To Revenue0.210.220.2663
Slightly volatile
Average Inventory256.4 M288.5 M314.9 M
Slightly volatile
Research And Ddevelopement To Revenue1.010.941.1187
Slightly volatile
Capex To Revenue0.360.190.5759
Slightly volatile
Cash Per Share65.9862.8320.5762
Slightly volatile
Payout Ratio0.04030.04540.0495
Slightly volatile
Days Payables Outstanding272259168
Very volatile
Intangibles To Total Assets0.08480.05980.0595
Pretty Stable
Current Ratio4.076.715.3119
Pretty Stable
Receivables Turnover1.972.087.7685
Slightly volatile
Capex Per Share1.781.690.7907
Slightly volatile
Revenue Per Share17.9610.312.3409
Slightly volatile
Interest Debt Per Share0.631.00.5609
Slightly volatile
Debt To Assets0.01230.0130.0565
Slightly volatile
Graham Number11477.051.6313
Slightly volatile
Operating Cycle372354158
Slightly volatile
Days Of Payables Outstanding272259168
Very volatile
Dividend Payout Ratio0.04030.04540.0495
Slightly volatile
Ebt Per Ebit0.560.591.1912
Slightly volatile
Long Term Debt To Capitalization0.00950.010.0968
Slightly volatile
Total Debt To Capitalization0.01410.01493.0359
Very volatile
Quick Ratio3.996.615.2282
Pretty Stable
Cash Ratio2.683.484.0287
Slightly volatile
Days Of Inventory Outstanding18117260.4608
Slightly volatile
Days Of Sales Outstanding11018292.9869
Slightly volatile
Fixed Asset Turnover1.992.094.4736
Slightly volatile
Debt Ratio0.01230.0130.0565
Slightly volatile
Price Sales Ratio10.3810.9231.8603
Slightly volatile
Asset Turnover0.10.110.2527
Pretty Stable

BioNTech Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B2.6 B2.9 B
Slightly volatile
Enterprise Value3 B3 B2.7 B
Pretty Stable

BioNTech Fundamental Market Drivers

Forward Price Earnings7.0373
Cash And Short Term Investments16.8 B

BioNTech Upcoming Events

25th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
25th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue339.1 M192.3 M
Total Revenue3.2 B6 B
Cost Of Revenue622.5 M982.8 M
Stock Based Compensation To Revenue 0.04  0.08 
Sales General And Administrative To Revenue 0.22  0.21 
Research And Ddevelopement To Revenue 0.94  1.01 
Capex To Revenue 0.19  0.36 
Revenue Per Share 10.30  17.96 
Ebit Per Revenue(0.43)(0.41)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VGIAXVanguard Growth And
XARSPDR SP Aerospace
XARSPDR SP Aerospace

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY